Heilongjiang Zbd Pharmaceutical Co.Ltd(603567)
Independent opinions of independent directors on relevant deliberations of the 16th session of the 4th board of directors
In accordance with the guiding opinions on the establishment of independent director system in listed companies and other laws and regulations of the CSRC and the relevant provisions of the articles of association, as an independent director of the company, he reviewed the relevant matters considered at the 16th meeting of the Fourth Board of directors, and expressed the following independent opinions on the relevant proposals based on the principles of independence, objectivity and fair judgment:
1、 Proposal on using raised funds to replace self raised funds invested in raised investment projects in advance
The replacement time of the funds raised by the company’s non-public offering of shares is less than six months from the time of receipt of the funds raised, which meets the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of the funds raised by listed companies Relevant provisions such as the measures for the administration of raised funds of listed companies of Shanghai Stock Exchange (revised in 2013) and the requirements of the company’s raised funds management system. The company has fulfilled the necessary deliberation and decision-making procedures. The use of raised funds to replace the self raised funds invested in the raised funds investment project in advance does not conflict with the implementation plan of the raised funds investment project, does not affect the normal progress of the raised funds investment project, and does not change the investment direction of the raised funds in a disguised manner and damage the interests of shareholders.
In conclusion, we agree that the company will use the raised funds to replace the self raised funds invested in the raised funds investment projects in advance. 2、 Proposal on using some idle raised funds for cash management
The decision-making procedures and contents of the company’s use of some temporarily idle raised funds for cash management comply with the relevant provisions of the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies of China Securities Regulatory Commission and the measures for the administration of raised funds by listed companies of Shanghai Stock Exchange, It will not affect the construction of investment projects with raised funds and the use plan of raised funds, improve the use efficiency of raised funds and increase the company’s income. There is no change or disguised change in the use of raised funds, which is in line with the interests of the company and all shareholders.
In conclusion, we agree that the company uses some idle raised funds for cash management. (no text below)
(there is no text on this page, which is the signature page of Heilongjiang Zbd Pharmaceutical Co.Ltd(603567) independent directors’ independent opinions on relevant deliberations of the 16th session of the 4th board of directors) signature of independent directors:
Cui Shaohua: Lin Ruichao:
specific date
